Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Review Status	Status Date	View
JYSB2101174	人胰岛素注射液	human insulin	Injection	Biological Products	Supplementary Application	2021-11-29	Lilly France			view
CYSB2200088	精蛋白人胰岛素注射液	Isophane Protamine Human Insulin	Injection	Biological Products	Supplementary Application	2022-03-18	Novo Nordisk (China) Pharmaceuticals Co Ltd			view
JYSZ2100511	精蛋白人胰岛素注射液	Isophane Protamine Human Insulin	Injection	Biological Products	License Renew	2021-04-23				view
CYSB2300203	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2023-11-03	Novo Nordisk (China) Pharmaceuticals Co Ltd			view
J0401635	精蛋白生物合成人胰岛素注射液（预混30/70）		Injection	Biological Products(15)	Import Drug Application	2004-09-09	Shanghai Tianli Business Consulting Co Ltd	Certificate Issued	2005-11-09	view
JYSB2101173	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2021-11-29	Lilly France			view
J0300367	中效人胰岛素注射液		Injection	Chemical Drugs	License Renew	2003-04-08		Certificate Issued	2003-12-22	view
JYSZ2100505	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2021-04-21				view
J0400205	常规人重组胰岛素	human insulin	Active ingredient	Biological Products(7)	Import Drug Application	2004-12-28	Hainan Zeying MEDICINE & HEALTH CARE Co Ltd	Certificate Issued	2005-11-08	view
CYSB2101284	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2021-12-10	Novo Nordisk (China) Pharmaceuticals Co Ltd			view
CYSB2101283	人胰岛素注射液	human insulin	Injection	Biological Products	Supplementary Application	2021-12-10	Novo Nordisk (China) Pharmaceuticals Co Ltd			view
JYSZ2300006	人胰岛素注射液	human insulin	Injection	Biological Products	License Renew	2023-02-14				view
JYSZ2200062	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2022-11-08				view
JYSZ2100508	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2021-04-21				view
CYSB2101285	精蛋白人胰岛素混合注射液（50R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2021-12-10	Novo Nordisk (China) Pharmaceuticals Co Ltd			view
JYSZ2200014	人胰岛素注射液	human insulin	Injection	Biological Products	License Renew	2022-04-14				view
JYSZ2100526	人胰岛素注射液	human insulin	Injection	Biological Products	License Renew	2021-08-05				view
CYSB2200233	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2022-09-23	Gan & Lee Pharmaceuticals			view
CYSB2300105	精蛋白人胰岛素混合注射液（50R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2023-06-03	Novo Nordisk (China) Pharmaceuticals Co Ltd			view
J0401634	精蛋白生物合成人胰岛素注射液（预混30/70）		Injection	Biological Products(15)	Import Drug Application	2004-09-09	Shanghai Tianli Business Consulting Co Ltd	Certificate Issued	2005-11-09	view